Eximore Business
Product stage
Clinical Trial
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug DeliveryMedical DevicesMedical Treatment & Therapeutics
Target Customer
Healthcare & Life SciencesHealthcareProviders
Core Technology
Materials & Substances
Tags (12)
bioconvergencepersonalizationnon-invasiveeye-diseasesmedical-technologiesdrug-deliveryophthalmologyglaucomamedical-devicesadherenceclinicsbiopharmaceutical
Eximore Financials
Undisclosed
Capital raised
Cumulative Funding Raised Over Time ($)
$600KDec 2013
$3.6MMay 2018
Private Equity Funding
VLX Ventures, Rimonci Capital, Docor International Management
VLX Ventures, Xenia Venture Capital
Eximore Lifecycle
Cumulative Funding Raised Over Time
$600KDec 2013
$3.6MMay 2018
All Events
VLX Ventures, Rimonci Capital, Docor International Management
VLX Ventures, Xenia Venture Capital
Eximore News
0 articles
No news articles.
Eximore Team
Eyal Sheetrit
Co-founder & CEO
Founder
Employee Info
| Employees (range) | 1-10 |
| Exact count | 3 |
| Team members | 1 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 9 classification IDs that could be used for matching.